RAMM fundamentals
An in-depth look to RAMM PHARMA CORP. operating, investing, and financing activities
RAMM free cash flow for Q4 24 is -680.24 k CAD. For 2024, RAMM free cash flow was -4.05 M CAD and operating cash flow was -4 M CAD.
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−1.35 M
−900.00 K
−450.00 K
0.00
450.00 K
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q1 '20
Jan 2020
Q2 '20
Apr 2020
Q3 '20
Jul 2020
Q4 '20
Oct 2020
Q1 '21
Jan 2021
Q2 '21
Apr 2021
Q3 '21
Jul 2021
Q4 '21
Oct 2021
Q1 '22
Jan 2022
Q2 '22
Apr 2022
Q3 '22
Jul 2022
Q4 '22
Oct 2022
Q1 '23
Jan 2023
Q2 '23
Apr 2023
Q3 '23
Jul 2023
Q4 '23
Oct 2023
Q1 '24
Jan 2024
Q2 '24
Apr 2024
Q3 '24
Jul 2024
Q4 '24
Oct 2024
TTM
Cash from operating activitiesYoY growth
−1.13 M
−1.20%
−1.23 M
+34.68%
−656.30 K
+22.16%
−1.25 M
+37.17%
−1.18 M
−4.57%
−1.02 M
+16.77%
−1.14 M
−73.32%
−658.33 K
+47.15%
−4.00 M
Cash from investing activitiesYoY growth
56.22 K
—
−78.09 K
−102.51%
30.58 K
—
−11.64 K
+98.80%
26.45 K
−52.96%
−58.84 K
+24.66%
−37.60 K
−222.96%
22.56 K
—
−47.43 K
Cash from financing activitiesYoY growth
−142.14 K
−2.47%
−79.59 K
−108.92%
−179.89 K
+82.04%
−8.35 K
+92.07%
−56.34 K
+60.37%
−74.11 K
+6.89%
−66.58 K
+62.99%
−61.20 K
−633.26%
−258.23 K
Free cash flowYoY growth
−1.14 M
+10.02%
−1.23 M
+34.55%
−656.32 K
+23.93%
−1.30 M
+34.55%
−1.19 M
−5.08%
−1.02 M
+16.96%
−1.15 M
−75.22%
−680.24 K
+47.60%
−4.05 M